A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)
PHASE1CompletedINTERVENTIONAL
Enrollment
14
Participants
Timeline
Start Date
March 28, 2025
Primary Completion Date
May 8, 2025
Study Completion Date
May 27, 2025
Conditions
Healthy
Interventions
DRUG
Belzutifan
Oral administration
DRUG
Phenytoin
Oral administration
Trial Locations (1)
85283
Celerion, Inc. ( Site 0001), Tempe
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT06903715 - A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035) | Biotech Hunter | Biotech Hunter